DiviDrip · AURA

AURA — Aura Biosciences, Inc.

AURA is Aura Biosciences, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $7.56. Market cap: $784M. Capital Quality Rank: 50/100 — Stagnant mediocrity.

Stock snapshot

Price$7.56
Market cap$784M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)50 / 100 · Stagnant mediocrity
ROIC (TTM)-23.0%
Shareholder buyback yield-17.71%
Altman Z-score zoneSafe

About AURA

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Listed2021Employees113HQBoston, MASectorHealthcareWebsiteaurabiosciences.com

Related non-dividend companies

Other non-dividend stocks investors research alongside AURA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is AURA's current stock price?

AURA (Aura Biosciences, Inc.) is currently trading at $7.56.

Does AURA pay a dividend?

AURA (Aura Biosciences, Inc.) does not currently pay a regular dividend.

What is AURA's Capital Quality Rank?

AURA has a Capital Quality Rank of 50/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AURA in DiviDrip

Add AURA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow